RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $478

Benzinga · 5d ago
RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $462 to $478.